Happel David
SEC CIK 1623567 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | Pres, CEO, Dir | 741.6K | $71.7K | $1.16M | 9 | 2023-11-16 | 2026-07-20 |
Most active insiders at SGMT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kemble George | Executive COB, Dir | — | $4.22M |
| 2 | Happel David | Pres, CEO, Dir | — | $561.9K |
| 3 | Rozek Elizabeth | Chief Legal, Admin. Off | — | $95.9K |
| 4 | Martins Eduardo Bruno | Chief Medical Off | — | $19.5K |
| 5 | Chauche Thierry | CFO | — | $7,032 |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-22 16:05 | 2026-07-20 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | S - Sale | $7.76 | -64.1K | 741.6K | -8% | -$497.1K | |
| D | 2026-02-20 | 2026-02-19 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | A - Grant | $0.00 | +128.0K | 805.6K | +19% | $0 |
| 2026-02-12 | 2026-02-10 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | S - Sale | $5.36 | -12.1K | 677.6K | -2% | -$64.9K | |
| 2025-07-23 | 2025-07-21 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | S - Sale | $9.13 | -65.5K | 689.7K | -9% | -$597.8K | |
| D | 2025-02-07 | 2025-02-06 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | A - Grant | $0.00 | +116.0K | 755.2K | +18% | $0 |
| 2024-03-28 | 2024-03-26 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | P - Purchase | $5.27 | +12.1K | 639.2K | +2% | +$63.8K | |
| 2023-12-08 | 2023-12-07 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | P - Purchase | $4.10 | +1,600 | 627.1K | +0.3% | +$6,560 | |
| 2023-11-21 | 2023-11-17 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | A - Grant | $0.00 | +624.9K | 625.5K | +105,917% | $0 | |
| 2023-11-20 | 2023-11-16 | SGMT | Sagimet Biosciences Inc. | Happel David | Pres, CEO, Dir | P - Purchase | $2.35 | +590 | 590 | New | +$1,386 |
Purchase Sale Sale after option exercise All abbreviations